Welcome to our dedicated page for SRGA news (Ticker: SRGA), a resource for investors and traders seeking the latest updates and insights on SRGA stock.
Surgalign Holdings, Inc. (SRGA) delivers cutting-edge medical technologies that enhance surgical outcomes across orthopedics, spine care, and trauma procedures. This dedicated news hub provides investors and healthcare professionals with essential updates about the company’s advancements in surgical implant solutions.
Access authoritative information on SRGA’s financial performance, product innovations, and regulatory milestones. Track developments surrounding flagship technologies like the Coflex Interlaminar Stabilization Device and Simmetry Sacroiliac Joint Fusion System, which demonstrate the company’s commitment to reducing postoperative complications and improving patient recovery.
Our curated news collection features earnings announcements, partnership updates, and clinical study results – all vital for understanding SRGA’s market position. Discover how the company’s direct distribution network and TETRAfuse 3D technology continue shaping the future of spinal fusion procedures worldwide.
Bookmark this page for streamlined access to Surgalign Holdings’ official communications and third-party analyses. Stay informed about strategic initiatives from this Deerfield-based innovator through our continuously updated news repository.
Surgalign Spine Technologies (NASDAQ: SRGA) reported first-quarter 2021 results with global spine revenue of $23.3 million, down from $27.1 million in Q1 2020. The company experienced a net loss from continuing operations of $15.2 million, which includes $3.2 million in non-recurring charges. Adjusted EBITDA loss improved to $9.8 million from $20.1 million year-over-year. Surgalign appointed Marc Mackey as Executive VP, Digital Surgery, and filed a 510(k) for the Holo Surgical intelligent guidance system, a key milestone for the year.
Surgalign Spine Technologies (NASDAQ: SRGA) announced the submission of a premarket notification 510(k) to the FDA for its innovative digital surgical guidance system. This system integrates augmented reality (AR) and artificial intelligence (AI) to provide real-time surgical guidance, enhancing accuracy in spinal surgeries. Developed over six years, this system allows surgeons to visualize patient-specific anatomy during procedures. The company aims to improve the efficiency of over 1.5 million annual instrumented spinal surgeries in the U.S. with this ground-breaking technology.
Surgalign Spine Technologies (NASDAQ: SRGA) has acquired a medical device machine shop to enhance its Spine Innovation Center in San Diego. The acquisition aims to streamline research and development by integrating advanced prototyping and manufacturing capabilities. This move is projected to shorten product development timelines and improve quality control. Surgalign's President, Terry Rich, expressed confidence that this will lead to superior products and better customer solutions, reinforcing the company’s commitment to advancing digital surgery in spine care.
Surgalign Spine Technologies (NASDAQ: SRGA) announced it will release its first quarter 2021 financial results on May 10, 2021, after the market closes. The company will hold a conference call and audio webcast at 4:30 p.m. ET on the same day. Interested parties can access the call by calling (877) 383-7419 or visiting Surgalign's investor website. The conference call replay will be available for one month. Surgalign focuses on advancing digital surgery technologies aimed at improving surgical outcomes globally.
Surgalign Spine Technologies (NASDAQ: SRGA) appointed Marc Mackey as Executive Vice President of Digital Surgery, effective immediately. Mackey, who has over 25 years of experience in orthopedic and surgical technology, will lead efforts to develop digital surgery solutions. His role involves managing the Digital Surgery Team, formed after Surgalign's acquisition of Holo Surgical in 2020. The company aims to redefine surgical practices using technology to enhance patient outcomes. CEO Terry Rich emphasized the need for experienced leadership to advance digital surgery initiatives.
Surgalign Holdings, Inc. (Nasdaq: SRGA), a leader in medical technology, is set to present at the Sidoti Virtual Investor Conference on March 25, 2021, at 10:45 a.m. Eastern Time. The presentation will highlight the company’s commitment to advancing spine surgery and enhancing patient outcomes through digital technology. Attendees can access a live audio webcast on Surgalign's investor relations page, with a replay available later. The company, headquartered in Deerfield, IL, operates worldwide and focuses on delivering innovative spine care solutions.
Surgalign Holdings, Inc. (Nasdaq: SRGA) reported Q4 2020 results with global spine revenue at $26.2 million, down from $31.6 million year-over-year, primarily due to COVID-19 impacts. The company incurred a net loss of $118 million, which included $101 million in non-recurring charges. Adjusted EBITDA loss was $7.7 million, showing improvement from the previous year's loss. The company completed a $40 million equity financing in Q1 2021 and anticipates 7-10% revenue growth for 2021, assuming a return to normal procedure volumes.
Surgalign Holdings, Inc. (Nasdaq: SRGA) announced a change in its earnings release date for the fourth quarter and full year 2020 due to delays in completing financial statements related to the OEM business sale. The new release date is set for March 16, 2021, post-market close. A conference call will follow at 4:30 p.m. ET, accessible via phone and webcast. Surgalign focuses on innovative spine care solutions, aiming to enhance surgical outcomes and improve patient lives.
Surgalign Holdings, Inc. (Nasdaq: SRGA) announced plans to release its financial results for Q4 and the full year 2020 on March 11, 2021, after market close. A conference call is scheduled for 4:30 p.m. ET that day, accessible via U.S. and international dialing options. The company focuses on spine surgery advancements and improving patient outcomes through digital technology. It operates in over 50 countries, driven by a commitment to clinical innovation. Interested parties can access the conference call via the investor section of Surgalign's website.
Surgalign Holdings, Inc. (Nasdaq: SRGA) has announced its 2021 Annual Meeting of Stockholders will occur virtually on May 4, 2021, at 9:00 A.M. Central Time. Stockholders of record by March 15, 2021, can vote on meeting matters. Proposals for the meeting must be submitted by February 22, 2021, per SEC regulations. Proxy materials will be mailed around March 30, 2021. The company focuses on innovative solutions in spine care to improve surgical outcomes, distributing products across the U.S. and over 40 countries.
